Mesoblast LtdNASDAQ:MESO
- LAST PRICE7.2700
- TODAY'S CHANGE (%)0.5300 (7.8635%)
- Bid / Lots7.1400/ 1
- Ask / Lots7.3800/ 1
- Open / Previous Close7.0700 / 6.7400
- Day Range
- 52 Week Range
- Volume190,406
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MESO |
|---|---|---|
| 09:32 ET | 1992 | 7.07 |
| 09:34 ET | 2271 | 7.01 |
| 09:36 ET | 312 | 6.97 |
| 09:38 ET | 2962 | 6.99 |
| 09:39 ET | 6177 | 7.14 |
| 09:41 ET | 12380 | 7.21 |
| 09:43 ET | 2800 | 7.2 |
| 09:45 ET | 3618 | 7.2 |
| 09:52 ET | 2105 | 7.18 |
| 09:54 ET | 500 | 7.15 |
| 09:57 ET | 280 | 7.15 |
| 09:59 ET | 1819 | 7.05 |
| 10:03 ET | 2100 | 7.09 |
| 10:08 ET | 200 | 7.0983 |
| 10:10 ET | 1000 | 7.075293 |
| 10:12 ET | 1319 | 7.15 |
| 10:15 ET | 100 | 7.175 |
| 10:17 ET | 2992 | 7.13 |
| 10:26 ET | 300 | 7.12 |
| 10:28 ET | 4740 | 7.13 |
| 10:30 ET | 500 | 7.1 |
| 10:32 ET | 100 | 7.135 |
| 10:33 ET | 550 | 7.115 |
| 10:35 ET | 507 | 7.15 |
| 10:39 ET | 100 | 7.145 |
| 10:44 ET | 300 | 7.17 |
| 10:50 ET | 100 | 7.15 |
| 10:51 ET | 300 | 7.1543 |
| 10:53 ET | 100 | 7.16 |
| 10:55 ET | 500 | 7.14 |
| 11:00 ET | 100 | 7.115 |
| 11:04 ET | 100 | 7.15 |
| 11:06 ET | 100 | 7.15 |
| 11:09 ET | 788 | 7.15 |
| 11:15 ET | 150 | 7.1422 |
| 11:18 ET | 9000 | 7.0701 |
| 11:22 ET | 200 | 7.105 |
| 11:24 ET | 241 | 7.09 |
| 11:26 ET | 100 | 7.12 |
| 11:29 ET | 100 | 7.13 |
| 11:31 ET | 100 | 7.14 |
| 11:36 ET | 100 | 7.14 |
| 11:40 ET | 100 | 7.14 |
| 11:42 ET | 200 | 7.14 |
| 11:47 ET | 1600 | 7.14 |
| 11:51 ET | 100 | 7.105 |
| 11:54 ET | 2700 | 7.13 |
| 11:56 ET | 300 | 7.11 |
| 12:02 ET | 300 | 7.15 |
| 12:03 ET | 100 | 7.15 |
| 12:05 ET | 1448 | 7.14 |
| 12:07 ET | 100 | 7.11 |
| 12:12 ET | 100 | 7.1526 |
| 12:16 ET | 100 | 7.17 |
| 12:18 ET | 100 | 7.15 |
| 12:21 ET | 200 | 7.14 |
| 12:23 ET | 1469 | 7.17 |
| 12:25 ET | 183 | 7.14 |
| 12:30 ET | 100 | 7.14 |
| 12:32 ET | 190 | 7.2 |
| 12:38 ET | 17909 | 7.18 |
| 12:39 ET | 100 | 7.22 |
| 12:41 ET | 1100 | 7.215 |
| 12:43 ET | 1935 | 7.165 |
| 12:45 ET | 100 | 7.21 |
| 12:48 ET | 2402 | 7.16 |
| 12:50 ET | 200 | 7.14 |
| 12:52 ET | 6828 | 7.12 |
| 12:54 ET | 100 | 7.12 |
| 12:56 ET | 100 | 7.07 |
| 12:57 ET | 200 | 7.07 |
| 01:01 ET | 200 | 7.16 |
| 01:06 ET | 2700 | 7.1501 |
| 01:08 ET | 700 | 7.1493 |
| 01:14 ET | 100 | 7.15 |
| 01:15 ET | 400 | 7.15 |
| 01:17 ET | 228 | 7.1567 |
| 01:19 ET | 1000 | 7.17 |
| 01:21 ET | 100 | 7.17 |
| 01:26 ET | 200 | 7.16 |
| 01:28 ET | 300 | 7.16 |
| 01:30 ET | 2590 | 7.185 |
| 01:32 ET | 200 | 7.16 |
| 01:37 ET | 788 | 7.18 |
| 01:42 ET | 100 | 7.17 |
| 01:44 ET | 100 | 7.17 |
| 01:50 ET | 100 | 7.17 |
| 01:51 ET | 200 | 7.18 |
| 01:55 ET | 100 | 7.16 |
| 01:57 ET | 100 | 7.21 |
| 02:04 ET | 100 | 7.2 |
| 02:09 ET | 100 | 7.2 |
| 02:11 ET | 407 | 7.2 |
| 02:15 ET | 603 | 7.17 |
| 02:22 ET | 299 | 7.17 |
| 02:26 ET | 140 | 7.1509 |
| 02:29 ET | 100 | 7.17 |
| 02:31 ET | 200 | 7.17 |
| 02:33 ET | 100 | 7.17 |
| 02:40 ET | 100 | 7.17 |
| 02:44 ET | 100 | 7.17 |
| 02:51 ET | 1797 | 7.17 |
| 02:54 ET | 2781 | 7.22 |
| 02:56 ET | 906 | 7.25 |
| 02:58 ET | 2667 | 7.25 |
| 03:00 ET | 1625 | 7.25 |
| 03:02 ET | 2582 | 7.24 |
| 03:03 ET | 2795 | 7.25 |
| 03:05 ET | 405 | 7.25 |
| 03:07 ET | 1010 | 7.25 |
| 03:09 ET | 1700 | 7.26 |
| 03:12 ET | 100 | 7.25 |
| 03:14 ET | 200 | 7.24 |
| 03:18 ET | 3800 | 7.24 |
| 03:21 ET | 600 | 7.18 |
| 03:23 ET | 420 | 7.17 |
| 03:30 ET | 400 | 7.18 |
| 03:32 ET | 500 | 7.22 |
| 03:34 ET | 19203 | 7.39 |
| 03:36 ET | 500 | 7.315 |
| 03:38 ET | 700 | 7.27 |
| 03:39 ET | 3000 | 7.19 |
| 03:41 ET | 2407 | 7.19 |
| 03:43 ET | 1400 | 7.235 |
| 03:45 ET | 300 | 7.19 |
| 03:48 ET | 700 | 7.235 |
| 03:52 ET | 100 | 7.27 |
| 03:54 ET | 224 | 7.19 |
| 03:56 ET | 200 | 7.29 |
| 03:57 ET | 100 | 7.28 |
| 03:59 ET | 3267 | 7.27 |
Today
DJ Mesoblast Raised to Buy From Hold by Maxim Group, from 7 hours ago by Dow Jones
7 hours ago by Dow Jones
Aug 29, 2024
DJ Mesoblast Raised to Buy From Hold by Jefferies, from 11:37AM ET on Thursday Aug 29, 2024 by Dow Jones
11:37AM ET on Thursday Aug 29, 2024 by Dow Jones*DJ Mesoblast Upgraded to Buy from Hold by Jefferies, from 1:43AM ET on Thursday Aug 29, 2024 by Dow Jones
1:43AM ET on Thursday Aug 29, 2024 by Dow Jones
Aug 28, 2024
Press Release: Mesoblast Reports Financial Results and Operational Update for Fiscal Year Ended June 30, 2024, from 7:27PM ET on Wednesday Aug 28, 2024 by Dow Jones
7:27PM ET on Wednesday Aug 28, 2024 by Dow JonesMesoblast Reports Financial Results and Operational Update for Fiscal Year Ended June 30, 2024, from 7:27PM ET on Wednesday Aug 28, 2024 by Dow Jones
7:27PM ET on Wednesday Aug 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mesoblast Ltd | 784.9M | -8.3x | --- |
Dianthus Therapeutics Inc | 768.2M | -5.0x | --- |
Arrivent Biopharma Inc | 760.4M | -9.6x | --- |
Savara Inc | 758.8M | -10.2x | --- |
89Bio Inc | 812.3M | -3.8x | --- |
Oric Pharmaceuticals Inc | 756.9M | -6.1x | --- |
Company Information
Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.
Contact Information
- Headquarters
- L 38 55 Collins StMELBOURNE, VIC, Australia 3000
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Jane Bell
- Chief Executive Officer, Executive Director
- Silviu Itescu
- Non-Executive Independent Vice Chairman of the Board
- William Burns
- Interim Chief Financial Officer
- Andrew Chaponnel
- Chief Operating Officer
- Dagmar Rosa-Bjorkeson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $784.9M |
|---|---|
Revenue (TTM) | $5.9M |
Shares Outstanding | 114.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.47 |
EPS | $-0.88 |
Book Value | $4.21 |
P/E Ratio | -8.3x |
Price/Sales (TTM) | 133.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,173.11% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
